The potential role of mycotoxins as a contributor to stunting in the SHINE Trial

53Citations
Citations of this article
230Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Children in developing countries experience multiple exposures that are harmful to their growth and development. An emerging concern is frequent exposure to mycotoxins that contaminate a wide range of staple foods, including maize and groundnuts. Three mycotoxins are suspected to contribute to poor child health and development: aflatoxin, fumonisin, and deoxynivalenol. We summarize the evidence that mycotoxin exposure is associated with stunting, and propose that the causal pathway may be through environmental enteric dysfunction (EED) and disturbance of the insulin-like growth factor 1 (IGF-1) axis. The objectives of this substudy are to assess the relationship between agricultural and harvest practices and mycotoxin exposure; to evaluate associations between mycotoxin exposure and child stunting; and to investigate EED as a potential pathway linking mycotoxin exposure to child stunting, to inform potential areas for intervention.

Cite

CITATION STYLE

APA

Smith, L. E., Prendergast, A. J., Turner, P. C., Mbuya, M. N. N., Mutasa, K., Kembo, G., & Stoltzfus, R. J. (2015). The potential role of mycotoxins as a contributor to stunting in the SHINE Trial. Clinical Infectious Diseases, 61, S733–S737. https://doi.org/10.1093/cid/civ849

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free